Check out the companies making the biggest moves premarket: AstraZeneca — The pharma giant rose 3% after its experimental drug, tozorakimab, was found to meaningfully reduce flare-ups in cases of ...
Unity CEO Matthew Bromberg announced preliminary Q1 2026 results beating guidance across the board: revenue $505–$508M vs. $480–$490M guided, EBITDA up 58% YoY at ~26% margin. Unity is exiting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results